Wood, Kris Cameron
kris.wood@duke.edu

Webpages

Courses

BIOLOGY 728E: University Program in Genetics and Genomics Biological Solutions Module V
MGM 778E: University Program in Genetics and Genomics Biological Solutions Module V
CMB 710E: Cell & Molecular Biology Module V
PHARM 394: Research Independent Study
MOLCAN 818: Molecular Mechanisms of Oncogenesis

Kris Cameron Wood

Associate Professor of Pharmacology and Cancer Biology
Assistant Professor of Pharmacology & Cancer Biology
Assistant Professor of Biomedical Engineering
Associate Professor of Cell Biology
Core Faculty in Innovation & Entrepreneurship
Member of the Duke Cancer Institute
Core Faculty in Innovation & Entrepreneurship
Our laboratory uses genomic and pharmacological approaches to understand how tumor dependencies are shaped by cell intrinsic factors, environmental factors, and drug treatments during the dynamic process of tumor evolution. To learn more, please visit our laboratory website: https://sites.duke.edu/woodlab/.

Education

  • Ph.D., Massachusetts Institute of Technology (2007)
  • B.S., University of Kentucky (2002)
  • B.S., University of Kentucky, Lexington (2002)
  • B.S., University of Kentucky at Lexington (2002)

Publications

Endogenous and imposed determinants of apoptotic vulnerabilities in cancer (02/2023)
MCB-613 exploits a collateral sensitivity in drug resistant EGFR -mutant non-small cell lung cancer through covalent inhibition of KEAP1. (01/2023)
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer. (01/2023)
Challenges and Emerging Opportunities for Targeting mTOR in Cancer. (11/2022)
Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies. (10/2022)
Cancer genes disfavoring T cell immunity identified via integrated systems approach. (08/2022)
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia. (07/2022)
Drivers of intrinsic resistance. (06/2022)
A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. (06/2022)
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma. (05/2022)

Mailing Address

Nicholas Institute for Energy, Environment & Sustainability
Box 90467
Durham, NC 27708

Street / Delivery Address

Nicholas Institute for Energy, Environment & Sustainability
140 Science Drive
Gross Hall, Suite 101
Durham, NC 27708

919-613-1305